Great post.
We are definitely at a fork in the road now. Either there are binding agreements being written up which were waiting for the positive feedback from the FDA or there are not and if there are not options to fund will be limited. Hopefully we could pit something together like OPT.
I have always thought this stock is unique in the sense that we don't own the product and I have always thought the IP surrounding the product would need to be really well understood by any prospective partner. Hence we kind of fall into a bit of a niche and are a higher risk of prosecution etc than most new drugs to enter the market, however our market is huge and the right deal would offset that risk.
As far as worrying about funding after the phase 3 trials for purchasing product, marketing etc I don't think that's a problem. We would be trading at much higher levels by this point..
Paul and co need to inform the market with a comprehensive update as to where we are at with next steps ASAP
- Forums
- ASX - By Stock
- Ann: PAR RECEIVES POSITIVE RESPONSE FROM US FDA FOR PHASE 3
Great post.We are definitely at a fork in the road now. Either...
-
- There are more pages in this discussion • 230 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.81M |
Open | High | Low | Value | Volume |
27.0¢ | 29.0¢ | 25.5¢ | $430.3K | 1.585M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5500 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 36162 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 61837 | 0.255 |
2 | 25200 | 0.250 |
1 | 15000 | 0.245 |
3 | 85000 | 0.240 |
1 | 8510 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 583 | 1 |
0.270 | 25000 | 1 |
0.275 | 3350 | 1 |
0.285 | 46000 | 1 |
0.290 | 44274 | 3 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |